About this trial
This study aims to preoperatively predict DFS of patients with localised ccRCC using a deep learning prognostic model based on enhanced contrast CT images, validate it's predictive ability in multicentre data and compare it's predictive ability with traditional models.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
underwent partial/radical nephrectomies
histologically diagnosed as ccRCC
with complete clinical data and preoperative CT image data
Disqualifiers
with incomplete clinic-pathological data
lack of preoperative contrast-enhanced CT images or the image quality was unsuitable for analysis
who received pre-surgery neoadjuvant or adjuvant therapies
with multiple renal tumors or/and had synchronous metastasis
Trial population
Patients admitted to urology departments at participating medical centres
Trial design
Cohort
Retrospective
Treatments tested in this trial
Not listed
Trial groups
Trial outcomes
Primary outcomes
disease-free survival (DFS)
the interval from the date of surgery to disease recurrence, all-cause mortality or the last visit
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Mingzhao Xiao
Lead sponsor
First Affiliated Hospital of Chongqing Medical University
Sponsor institution